ライフサイエンスコーパス: mechanical ventilation

1 e mechanical ventilation vs 72.4% short-term mechanical ventilation).

2 ng supplemental oxygen (3/23 high flow, 7/23 mechanical ventilation).

3 ntilator-free days (days alive and free from mechanical ventilation).

4 n only require it for a short term (< 4 d of mechanical ventilation).

5 ht sedation with a daily wake-up call during mechanical ventilation.

6 up after acute respiratory failure requiring mechanical ventilation.

7 re powerful with a difference in duration of mechanical ventilation.

8 ntification of patients in need of impending mechanical ventilation.

9 ted with various interventions, most notably mechanical ventilation.

10 acute mechanical ventilation than short-term mechanical ventilation.

11 plemental oxygen including 12 (12%) invasive mechanical ventilation.

12 espiratory failure; 75% (18 patients) needed mechanical ventilation.

13 e mechanical ventilation; or use of invasive mechanical ventilation.

14 e unit, with the majority of those requiring mechanical ventilation.

15 the delivery of volume- and pressure-limited mechanical ventilation.

16 ed with increased risk of encephalopathy and mechanical ventilation.

17 asal cannula, 78 (71.6%) ultimately received mechanical ventilation.

18 0%) and 374 of 1,373 (27%) required invasive mechanical ventilation.

19 rance, while limiting the harmful effects of mechanical ventilation.

20 3.09) independently associated with need for mechanical ventilation.

21 important risk factors for ICU admission and mechanical ventilation.

22 e; patients were eligible after weaning from mechanical ventilation.

23 acute mechanical ventilation than short-term mechanical ventilation.

24 loss of diaphragmatic force associated with mechanical ventilation.

25 experience rapid deterioration and need for mechanical ventilation.

26 roving care for patients receiving prolonged mechanical ventilation.

27 user-specified inspiratory breaths while on mechanical ventilation.

28 nflammation and respiratory failure, also on mechanical ventilation.

29 al CO2 removal combined with ultraprotective mechanical ventilation.

30 ia, 266,374 (38.5%) received prolonged acute mechanical ventilation.

31 ficantly reduced in the 3 subjects requiring mechanical ventilation.

32 Three patients required mechanical ventilation.

33 ications of altered respiratory drive during mechanical ventilation.

34 acute mechanical ventilation than short-term mechanical ventilation.

35 tion of patients with preventable harms from mechanical ventilation.

36 ulmonary oedema, hypoxaemia and the need for mechanical ventilation.

37 8 days, defined as being alive and free from mechanical ventilation.

38 or SARS-CoV-2 infection, including 7 days of mechanical ventilation.

39 level, was highly predictive of the need for mechanical ventilation.

40 tion, including 75% of patients who required mechanical ventilation.

41 ts among hospitalized patients not requiring mechanical ventilation.

42 re requiring vasopressors, hemodialysis, and mechanical ventilation.

43 itional critical care management and optimal mechanical ventilation.

44 nterstitial lung disease patients undergoing mechanical ventilation.

45 crobiologically confirmed COVID-19 receiving mechanical ventilation.

46 d positive end-expiratory pressure can guide mechanical ventilation.

47 nts with acute respiratory failure requiring mechanical ventilation.

48 t calstabin-1 6 hours after the onset of the mechanical ventilation, 1 and 10 days after extubation.

49 citation (including 23/29 [79%] who received mechanical ventilation); 13 met the American Heart Assoc

50 [67%] with a chronic disease), 31% received mechanical ventilation, 19% had shock, and 588 (3.1%) di

51 istory of venous thromboembolism (4 points), mechanical ventilation (2 points), lowest hemoglobin dur

52 ys vs. 6 days; p < 0.001), increased risk of mechanical ventilation (22.8% vs. 11.9%; adjusted odds r

53 Black patients also had the highest rates of mechanical ventilation (23.2%) and renal replacement the

54 mong those receiving oxygen without invasive mechanical ventilation (23.3% vs. 26.2%; rate ratio, 0.8

55 [CI], 24.9-25.6%), 14,498 underwent invasive mechanical ventilation (27.0%; 95% CI, 26.7-27.4%), and

56 care group among patients receiving invasive mechanical ventilation (29.3% vs. 41.4%; rate ratio, 0.6

57 p < 0.05), shorter duration of postoperative mechanical ventilation (35.0, 15.4-80.3 vs 94.0, 42.0-14

58 s with FIB-4 >=2.67 more frequently required mechanical ventilation (37.8% vs 18.3%; P = .009).

59 In total, 175 patients received mechanical ventilation; 44.6% were female, 66.3% were Bl

60 sions (88%), central venous catheters (86%), mechanical ventilation (59%), and high flow nasal cannul

61 nsive care unit (ICU) (4 vs 12 days), and on mechanical ventilation (6 vs 14.5 days) than those treat

62 are unit care, 320 (12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidn

63 ) received intensive care, 37 (20%) received mechanical ventilation, 90 (48%) received vasoactive sup

64 Among ICU patients requiring mechanical ventilation, a strategy of stress ulcer proph

65 ated with a lower odds of receiving invasive mechanical ventilation (adjusted generalized estimating

66 nt score, renal failure, encephalopathy, and mechanical ventilation (adjusted odds ratio, 1.43; 95% C

67 22.3%; 95% CI, 21.6-23.0%) required invasive mechanical ventilation after first receiving noninvasive

68 ng 1150 (88% [95% CI, 87%-90%]) who received mechanical ventilation and 137 (11% [95% CI, 9%-12%]) wh

69 to proportions in comparators; 18% required mechanical ventilation and 21% died during follow-up (co

70 spital lengths of stay, duration of invasive mechanical ventilation and extracorporeal carbon dioxide

71 ropic support, and in the most severe cases, mechanical ventilation and extracorporeal membrane oxyge

72 mon among critically ill patients undergoing mechanical ventilation and has been associated with adve

73 s disease 2019 (COVID-19) frequently require mechanical ventilation and have high mortality rates, bu

74 were older men, a large proportion required mechanical ventilation and high levels of PEEP, and ICU

75 Increasing time to mechanical ventilation and high-flow nasal cannula use m

76 acity was associated with longer duration of mechanical ventilation and hospitalization, and increase

77 The effects on the length of mechanical ventilation and ICU stay were only significan

78 , leading to more successful liberation from mechanical ventilation and improved survival.Conclusions

79 itation significantly shortens time spent on mechanical ventilation and in ICU, but this does not con

80 ventilation and subsequent need for invasive mechanical ventilation and in-hospital mortality among p

81 Outcomes included receipt of invasive mechanical ventilation and in-hospital mortality.

82 ry artery pressure in ICU patients receiving mechanical ventilation and may predict pulmonary hyperte

83 ory of HF was associated with higher risk of mechanical ventilation and mortality among patients hosp

84 ventilation decreases the need for invasive mechanical ventilation and mortality among patients with

85 Duration of mechanical ventilation and risk of death, hypoxic ischae

86 trative codes, we identified prolonged acute mechanical ventilation and short-term mechanical ventila

87 renic nerve stimulation leads in patients on mechanical ventilation and the feasibility of using this

88 The requirement of mechanical ventilation and vasopressive drugs were also

89 are hospital because of failure to wean from mechanical ventilation and who were receiving physical t

90 association with intensive care use (use of mechanical ventilation and/or admission to intensive car

91 gan Failure Assessment score and the need of mechanical ventilation and/or catecholamines.

92 tensive care with a requirement for invasive mechanical ventilation and/or vasoactive drug support fo

93 spiratory illness (including 9% who required mechanical ventilation) and 12% died within 30 d.

94 e mechanical ventilation vs 53.9% short-term mechanical ventilation), and race (white: 69.1% prolonge

95 th laboratory-confirmed botulism; 7 required mechanical ventilation, and 1 died.

96 hospitalized (376 [78%]), 117 (31%) required mechanical ventilation, and 77 (20.5%) died by 28 days a

97 rrival by ambulance, interhospital transfer, mechanical ventilation, and an emergency department tria

98 on, intensive care unit admission, intubated mechanical ventilation, and death) due to medically atte

99 on, intensive care unit admission, intubated mechanical ventilation, and death) for adults of all age

100 VID-19, intensive care unit [ICU] admission, mechanical ventilation, and death) were analyzed.

101 f stay, intensive care unit [ICU] admission, mechanical ventilation, and death) were collected from e

102 nd severe COVID-19, including ICU admission, mechanical ventilation, and death; associations with age

103 natremia was associated with encephalopathy, mechanical ventilation, and decreased probability of dis

104 ncluded encephalopathy, acute renal failure, mechanical ventilation, and discharge home compared acro

105 mission, need for oxygen supplementation and mechanical ventilation, and in-hospital case fatality (h

106 ength of stay, need for intensive care unit, mechanical ventilation, and in-hospital mortality) were

107 significant reductions in mortality, days on mechanical ventilation, and length of intensive care and

108 tensive care unit (ICU), new requirement for mechanical ventilation, and mortality.

109 with arterial blood gas values, duration of mechanical ventilation, and risk of death, hypoxic ische

110 Eighteen percent of patients were placed on mechanical ventilation, and the overall mortality rate w

111 e hospitalized, 26% underwent intubation and mechanical ventilation, and two deaths were reported.

112 e of oxygenation, renal replacement therapy, mechanical ventilation, and/or therapeutic plasmapheresi

113 95% CI, .83-.88) and more likely to require mechanical ventilation (aOR, 1.19; 95% CI, 1.05-1.36).

114 en after acute respiratory failure requiring mechanical ventilation are unknown.

115 n 48 h after diagnosis or while they were on mechanical ventilation, as well as patients who received

116 clusions: Among patients receiving prolonged mechanical ventilation at an LTACH, 53.7% were detached

117 Among the patients who were not undergoing mechanical ventilation at baseline, those in the hydroxy

118 [1.15, 1.38]) with corresponding decrease in mechanical ventilation at birth (0.89 [0.81, 0.97]) and

119 monia who had barotrauma related to invasive mechanical ventilation at the authors' institution were

120 er than in other patients requiring invasive mechanical ventilation at the authors' institution.

121 cation according to age and status regarding mechanical ventilation at trial entry.

122 Twenty-two patients required mechanical ventilation; at last follow-up, 16 were extub

123 05; 95% CI, 1.02-1.08; p = 0.001), length of mechanical ventilation (B coefficient, 0.66; 95% CI, 0.5

124 .16; 95% CI, 1.03-1.30; p = 0.02), length of mechanical ventilation (B coefficient, 0.80; 95% CI, 0.2

125 d (2) duration of oxygen supplementation and mechanical ventilation between the groups.

126 ult patients who were anticipated to require mechanical ventilation beyond the day after recruitment

127 in in-hospital mortality, ICU admission, or mechanical ventilation by race/ethnicity were found.

128 respiratory rate may become injurious during mechanical ventilation can be distinguished in two broad

129 4 (53.2%) had chosen to limit intubation and mechanical ventilation.Code status discussion was docume

130 oxemia and either a respiratory diagnosis or mechanical ventilation.Conclusions: An association betwe

131 o avoid both over- and under-assistance with mechanical ventilation, considering the patients' respir

132 Only mechanical ventilation days and acute renal failure requ

133 ement for organ support including receipt of mechanical ventilation, development of acute respiratory

134 After 6 hours of mechanical ventilation, diaphragm force production was d

135 rly tracheostomy was associated with shorter mechanical ventilation duration (-4.15 [95% CI, -6.30 to

136 th), ICU-free days during the first 28 days, mechanical ventilation duration at 28 days, and Sequenti

137 ays, ICU-free days during the first 28 days, mechanical ventilation duration at 28 days, or the 6-poi

138 In patients who undergo mechanical ventilation during surgery, the ideal tidal v

139 te respiratory distress syndrome on invasive mechanical ventilation during the previous 4 years (mean

140 In children on mechanical ventilation, early tracheostomy may improve i

141 Rationale: Patients receiving prolonged mechanical ventilation experience low survival rates and

142 ng both spontaneous breathing and controlled mechanical ventilation, external expiratory resistances

143 associated with a high frequency of invasive mechanical ventilation, extrapulmonary organ dysfunction

144 the strongest association with the need for mechanical ventilation, followed by maximal CRP level.

145 atistic 0.90), respiratory failure requiring mechanical ventilation for >=48 hours (c-statistic 0.86)

146 203 (79%) patients received invasive mechanical ventilation for a median of 18 days (IQR 9-28

147 Forty-two percent had mechanical ventilation for a median of 4 days (interquar

148 l center with COVID-19 who required invasive mechanical ventilation for greater than 2 weeks who were

149 Multivariable analyses revealed that mechanical ventilation for more than 24 hours after stat

150 Only 1 patient who needed mechanical ventilation for severe COVID-19 disease died

151 priority order, (1) survival at day 28, (2) mechanical ventilation-free days through day 28, and (3)

152 Coma-, delirium-, and invasive mechanical ventilation-free patients admitted to the ICU

153 included frequency and duration of invasive mechanical ventilation, frequency of vasopressor use and

154 ical ventilation vs 61.7 +/- 17.2 short-term mechanical ventilation), gender (males: 55.6% prolonged

155 The prolonged acute mechanical ventilation group had a higher comorbidity bu

156 Those undergoing prolonged acute mechanical ventilation (>= 4 d mechanical ventilation) r

157 sease 2019 (COVID-19) infection and invasive mechanical ventilation had a higher rate of barotrauma t

158 age, 64 years +/- 19; 52% men) with invasive mechanical ventilation had one barotrauma event (0.5%; 9

159 agm work using electrical stimulation during mechanical ventilation has been proposed to attenuate ve

160 frequency of jaundice, renal insufficiency, mechanical ventilation, high-level cytomegalovirus virem

161 linical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these gr

162 aO(2):FiO(2) ratio, Charlson index, baseline mechanical ventilation, hospitalization to inclusion lap

163 ere hypoxemic respiratory failure leading to mechanical ventilation, hypotension requiring vasopresso

164 ce intervals (CI) for predictors of invasive mechanical ventilation (IMV) and death.

165 Rationale: Patients who receive invasive mechanical ventilation (IMV) are usually exposed to opio

166 iratory distress syndrome requiring invasive mechanical ventilation (IMV).

167 .7%), in-hospital death in 1302 (17.1%), and mechanical ventilation in 1602 (21.1%).

168 stoperative complications included prolonged mechanical ventilation in 2 of 5 patients (40%), and ren

169 strictive lung disease requiring noninvasive mechanical ventilation in 3 patients, as well as recurre

170 pressure to zero may provide more protective mechanical ventilation in acute respiratory distress syn

171 nical ventilation were similar to short-term mechanical ventilation in age (years: 62.0 +/- 15.8 prol

172 ure (P(PL)) and worsening atelectasis during mechanical ventilation in patients with acute respirator

173 rates was associated with longer duration of mechanical ventilation in survivors (hazard ratio, 0.64;

174 In adults undergoing mechanical ventilation in the ICU, the use of conservati

175 ufficiency due to severe COVID-19, requiring mechanical ventilation in the ICU.

176 in the hospital, and 3 continued to receive mechanical ventilation in the ICU.

177 Patients who are undergoing mechanical ventilation in the intensive care unit (ICU)

178 the best strategies for optimizing invasive mechanical ventilation in this patient population.

179 the deleterious effects of positive-pressure mechanical ventilation in this patient population.

180 d are at higher risk of in-hospital death or mechanical ventilation, in particular, if young (age <=5

181 We report that mechanical ventilation is associated with a late diaphra

182 Mechanical ventilation is associated with primary diaphr

183 Duration of mechanical ventilation is only compared if both patients

184 ategies that may perhaps improve survival if mechanical ventilation is pursued in this set of patient

185 Mechanical ventilation is the standard treatment when vo

186 isease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear.

187 mes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and

188 ain, anxiety, adverse reactions, duration of mechanical ventilation, length of ICU and hospital stays

189 ressure sores; and shortened the duration of mechanical ventilation, length of intensive care unit st

190 has been associated with longer duration of mechanical ventilation, longer ICU and hospital length o

191 ence of ventricular tachycardia, duration of mechanical ventilation, major bleeding, occurrence of ac

192 s with COVID-19 infection underwent invasive mechanical ventilation (mean age, 63 years +/- 15 [stand

193 a higher comorbidity burden than short-term mechanical ventilation (mean Charlson Score 3.5 +/- 2.7

194 d controlled trials) but reduced duration of mechanical ventilation (mean difference, -1.7 d [-2.5 to

195 < 0.001) and increased duration of invasive mechanical ventilation (median 4 days [interquartile ran

196 In multivariable analysis, the hypotension, mechanical ventilation, mental status, and cardiac arres

197 e practices for patients receiving prolonged mechanical ventilation.Methods: We performed a focused e

198 ty rate, duration of hospital stay, need for mechanical ventilation (MV), virologic cure rate (VQR),

199 ry failure and at least 24 hours of invasive mechanical ventilation (n = 1,657).

200 As of April 4, 2020, for patients requiring mechanical ventilation (n = 1151, 20.2%), 38 (3.3%) were

201 and had more often a prolonged weaning from mechanical ventilation (n = 28, 64% vs n = 10, 26% in co

202 ive vasoactive-inotropic scores, duration of mechanical ventilation, need for renal replacement thera

203 ined as a potential predictor of noninvasive mechanical ventilation (NIV) failure in acute hypoxic de

204 Among 7606 patients, in-hospital death or mechanical ventilation occurred in 2109 (27.7%), in-hosp

205 II obese individuals were at higher risk for mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1

206 ed with higher risks of in-hospital death or mechanical ventilation (odds ratio, 1.28 [95% CI, 1.09-1

207 Mechanical ventilation (odds ratio, 3.25; 95% CI, 2.52-4

208 rience higher rates than those on short-term mechanical ventilation of hospital-acquired complication

209 By turning the mechanical ventilation on and off, it was demonstrated t

210 us sedation with a daily wake-up call during mechanical ventilation on cognitive function in adult su

211 h strong and weak respiratory efforts during mechanical ventilation on patient outcome brings attenti

212 Most patients requiring mechanical ventilation only require it for a short term

213 Median (interquartile range) post mechanical ventilation onset length of stay (13 [8-20] v

214 ine group had a higher frequency of invasive mechanical ventilation or death (30.7% vs. 26.9%; risk r

215 The primary outcome was mechanical ventilation or death by day 28.

216 27.4) in the placebo group (hazard ratio for mechanical ventilation or death, 0.56; 95% CI, 0.33 to 0

217 d of progression to the composite outcome of mechanical ventilation or death, but it did not improve

218 For adults not receiving mechanical ventilation or extracorporeal membrane oxygen

219 igh-flow oxygen; and 6.7% receiving invasive mechanical ventilation or extracorporeal membrane oxygen

220 defined as death or persistent dependency on mechanical ventilation or high-flow oxygen therapy.

221 ong those who were receiving either invasive mechanical ventilation or oxygen alone at randomization

222 ere increased in patients requiring invasive mechanical ventilation or patients who evolved with in-h

223 tive percentage of patients who had received mechanical ventilation or who had died by day 28 was 12.

224 ssessment score, and with the requirement of mechanical ventilation or/and vasoconstrictive agents du

225 Diabetes was a significant predictor for mechanical ventilation (OR 1.89; 95% CI 1.11-3.23) while

226 fidence interval [CI] 1.11 to 2.50), needing mechanical ventilation (OR 8.74, 95% CI 5.27 to 14.77),

227 ion (OR, 4.2; 95% CI, .5-33.7; P = .175) and mechanical ventilation (OR, 8.2; 95% CI, 7.6-8.9; P < .0

228 f severe illness (defined as intensive care, mechanical ventilation, or death) among patients who tes

229 oint of intensive care unit (ICU) admission, mechanical ventilation, or death.

230 In-hospital death, thromboembolism, mechanical ventilation, or hemodynamic decompensation ne

231 enal replacement therapy, longer duration of mechanical ventilation, or higher vasopressors and inotr

232 ce in initial static compliance, duration of mechanical ventilation, or ICU length of stay by timing

233 outcome (escalation to intensive care unit, mechanical ventilation, or in-hospital all-cause mortali

234 ion (intensive care unit admission, invasive mechanical ventilation, or vasopressor therapy) or in-ho

235 high-flow nasal cannula; use of non-invasive mechanical ventilation; or use of invasive mechanical ve

236 ase 2019, particularly among those requiring mechanical ventilation, our early experience indicates t

237 ventilator-free days (days alive and free of mechanical ventilation) over 28 days.

238 Although 27% of our patients needed mechanical ventilation, over half were discharged home b

239 s (P < 0.05), and more days without invasive mechanical ventilation (P < 0.06), compared with the con

240 acute mechanical ventilation and short-term mechanical ventilation patients and compared their basel

241 Prolonged acute mechanical ventilation patients exhibit a higher burden

242 ine if clinical course or characteristics of mechanical ventilation predict persistent respiratory mo

243 er C-reactive protein on admission, need for mechanical ventilation, presence of shock, and acute res

244 etween 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%.

245 Adjusted mechanical ventilation-related predictors of in-hospital

246 olonged acute mechanical ventilation (>= 4 d mechanical ventilation) represent a select cohort who fa

247 er one-third of all hospitalized patients on mechanical ventilation require it for greater than or eq

248 1.03-2.11) for requiring intensive care and mechanical ventilation, respectively.

249 apy (RR, 3.4; 95% CI, .5-21.1), and need for mechanical ventilation (RR, 4.1; 95% CI, 2.1-8.0) was al

250 soactive infusions, ventricular tachycardia, mechanical ventilation, sepsis, pulmonary hypertension,

251 findings may guide selection of personalized mechanical ventilation settings.

252 re unit (ICU) patients or patients requiring mechanical ventilation showed a lower proportion of medi

253 counting for oxygen requirement and need for mechanical ventilation, showed the HR for death and oral

254 ICU stays, and shorter duration and need for mechanical ventilation, showing clinical benefit associa

255 Residents completed an online virtual mechanical ventilation simulator either before or after

256 may be due in part to a lack of standardized mechanical ventilation strategies aimed at further minim

257 ess syndrome paradigm to see if any specific mechanical ventilation strategies might improve in-hospi

258 The same mechanical-ventilation strategies were used in both grou

259 ion at discharge a priori defined as one of: mechanical ventilation, supplemental oxygen, bronchodila

260 11.0); durations of vasoactive-inotropic and mechanical ventilation support were 3.0 days (2.0-6.0 d)

261 eline functional capacity and lower rates of mechanical ventilation than patients with CoS isolates.

262 all higher in the setting of prolonged acute mechanical ventilation than short-term mechanical ventil

263 3.5% vs 15.9%) was higher in prolonged acute mechanical ventilation than short-term mechanical ventil

264 ,071-$34,915] were higher in prolonged acute mechanical ventilation than short-term mechanical ventil

265 moves a relevant amount of CO2 thus allowing mechanical ventilation to be significantly reduced depen

266 th Covid-19 pneumonia who were not receiving mechanical ventilation to receive standard care plus one

267 th Covid-19 pneumonia who were not receiving mechanical ventilation, tocilizumab reduced the likeliho

268 rauma patients requiring more than 2 days of mechanical ventilation underwent HLA genotyping, and wer

269 f stay, hospital length of stay, duration of mechanical ventilation, use of renal replacement therapy

270 el for end-stage liver disease-sodium score, mechanical ventilation, vasopressor use, renal replaceme

271 a composite of 4 life-sustaining treatments: mechanical ventilation, vasopressors, dialysis, and card

272 r, higher C-reactive protein, and receipt of mechanical ventilation, vasopressors, renal replacement

273 Adults requiring invasive mechanical ventilation via endotracheal tube for acute r

274 ation), gender (males: 55.6% prolonged acute mechanical ventilation vs 53.9% short-term mechanical ve

275 in age (years: 62.0 +/- 15.8 prolonged acute mechanical ventilation vs 61.7 +/- 17.2 short-term mecha

276 ion), and race (white: 69.1% prolonged acute mechanical ventilation vs 72.4% short-term mechanical ve

277 4%), and the mortality of patients receiving mechanical ventilation was 19% (95% CI, 4-46%).

278 l patients, mortality for those who required mechanical ventilation was 35.7% (59/165), with 4.8% of

279 ong participants with PGD Grade 3, prolonged mechanical ventilation was associated with greater atten

280 The duration of mechanical ventilation was more often longer (>6 days) i

281 ch that the association of BMI with death or mechanical ventilation was strongest in adults <=50 year

282 Need for invasive mechanical ventilation was the primary endpoint.

283 In vivo, using mice exposed to mechanical ventilation, we found that the protective eff

284 3 score, vasoactive medication, and invasive mechanical ventilation were associated with severe acute

285 Among pregnant women, 93% of those on mechanical ventilation were extubated, 93% recovered, an

286 ived noninvasive ventilation before invasive mechanical ventilation were more likely to have comorbid

287 The need for hospitalization, ICU care, and mechanical ventilation were predicted with a validation

288 At baseline, patients on prolonged acute mechanical ventilation were similar to short-term mechan

289 apy from 0.4 FiO(2) Venturi mask to invasive mechanical ventilation) were evaluated to investigate th

290 s; median PaO(2):FiO(2) ratio, 151; 32.5% on mechanical ventilation) were evaluated.

291 erienced barotrauma associated with invasive mechanical ventilation, were compared with patients with

292 knowledge and improve knowledge retention in mechanical ventilation when compared with a clinical rot

293 ibrotic interstitial lung disease-associated mechanical ventilation when viewed through an acute resp

294 score (worst to best: death, cardiac arrest, mechanical ventilation with mechanical circulatory suppo

295 arterial lactate level >=4 mml/L (P = .013), mechanical ventilation with PaO(2) /FiO(2) <= 200 mm Hg

296 ilation with mechanical circulatory support, mechanical ventilation with vasopressors/inotrope suppor

297 Patients requiring invasive mechanical ventilation within 24 hours of ICU admission

298 tubation failure was defined as the need for mechanical ventilation within 48 hours.

299 tilation with vasopressors/inotrope support, mechanical ventilation without hemodynamic support, and

300 athing and from 32% to 18% during controlled mechanical ventilation, without increasing hyperinflatio